What do the latest data tell us about trends in drug use and the market? What hazardous new drugs are emerging? What substances are posing the greatest health threats? Find out more when the EU drugs agency (EMCDDA) launches its European Drug Report 2022: Trends and Developments in a live online press conference on 14 June.
Based on data from 29 countries (EU 27, Turkey and Norway), the report delivers the latest overview of the drug situation in Europe up to 2022, exploring long-term trends and emerging threats. The publication includes chapters on individual drugs, as well as on drug supply, production and precursors. National data sets are also provided across these themes and on key interventions.
Available in 25 languages, the publication is an essential resource for developing evidence-based policies and services. Accompanying the report will be the 2022 Statistical Bulletin, containing the European dataset underpinning the analysis. Also published on the day will be an update from the EU Early Warning System on new psychoactive substances as it celebrates its 25th anniversary.
Join us for the live online event to hear about the key issues and latest analysis.
Event details
Date: 14 June 2022 at 10.00 (Lisbon), 11.00 CET (Brussels)
Press conference (online):
- Ylva Johansson, European Commissioner for Home Affairs
- Franz Pietsch, Chair of the EMCDDA Management Board (Austria)
- Alexis Goosdeel, EMCDDA Director
Further details will be available in the run-up to the launch at: www.emcdda.europa.eu/edr2022
Embargoed report and interviews: press@emcdda.europa.eu
Languages: The press conference will be in English, with simultaneous interpretation available (ES, DE, FR, PT).
See news release below in 24 languages.
